PHIO PHARMACEUTICALS CORP. Fair Value of Assets Acquired
PHIO PHARMACEUTICALS CORP. (PHIO) reported Fair Value of Assets Acquired of $2.82 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2018-05-10
- PHIO PHARMACEUTICALS CORP. fair value of assets acquired for the quarter ending 2017-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. fair value of assets acquired for the quarter ending 2017-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. fair value of assets acquired for the quarter ending 2017-06-30 was $87.00K.
- PHIO PHARMACEUTICALS CORP. fair value of assets acquired for the quarter ending 2017-03-31 was $2.74M.
- PHIO PHARMACEUTICALS CORP. fair value of assets acquired for fiscal 2017 was $2.82M.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month | Fair Value of Assets Acquired 111 month | Fair Value of Assets Acquired 114 month | Fair Value of Assets Acquired 117 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | $0.00 derived: sum of 2 quarters · filed 2018-03-26 | $87.00K derived: sum of 3 quarters · filed 2018-03-26 | $2.82M 10-K · filed 2018-03-26 | |||
| 2017-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-03-26 | $87.00K derived: sum of 2 quarters · filed 2018-03-26 | $2.82M 10-Q/A · filed 2018-03-26 | ||||
| 2017-06-30 | $87.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-03-26 | $2.82M 10-Q/A · filed 2018-03-26 | |||||
| 2017-03-31 | $2.74M 10-Q · filed 2018-05-10 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $277.00K 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $277.00K 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $277.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |